Multicenter Open Prospective Comparative Non-interventional Study of Therapy for Threatened Miscarriage With Medicinal Products Utrogestan, 200 mg Capsules (Besins Healthcare SA, Belgium), and Duphaston, 10 mg Coated Tablets (Abbott Healthcare Products B.V., the Netherlands)
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Dydrogesterone (Primary) ; Progesterone (Primary) ; Progesterone (Primary)
- Indications Spontaneous abortion
- Focus Therapeutic Use
- Sponsors Besins Healthcare
- 17 Jan 2018 Status changed from recruiting to completed.
- 21 Oct 2017 New trial record
- 18 Oct 2017 Status changed from not yet recruiting to recruiting.